IDH1 and central nervous system cancer: Indeed, treatment of orthotopic xenograft GBM tumors with GLS inhibitors, including the most potent allosteric GLS inhibitor CB‐839, specifically sensitizes IDH‐mutant gliomas and not IDH‐wild type gliomas to radiation treatment [112].